Sphinxolide B

Star0

DB04783ExperimentalSmall molecule

Sphinxolide B: Overview.

Formula / weight: C₅₃H₈₅NO₁₄ · 960.2403 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL1615234PubChem46937020

Structure

InChIKeyMINVLQAHLUCDIO-GLLDUQGXSA-NSMILES

CO[C@H](C\C=C\N(C)C=O)[C@@H](C)C(=O)CC[C@H](C)[C@H](OC)[C@H](C)[C@H]1OC(=O)\C=C\C=C(C)/C[C@H](CC2=CC(=O)O[C@H]([C@H]2O)[C@H](C)[C@H](C[C@H](OC)\C=C\[C@H](C)[C@@H](O)C[C@@H](OC)\C=C\[C@@H]1C)OC)OC

Targets

P68133ACTA1

What you can answer from here — as of October 01, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Sphinxolide B, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account